Children

Saquinavir (Invirase) is not currently approved for use by children in the European Union. However, research has shown that saquinavir, in combination with other antiretroviral drugs, is effective in reducing viral load in children. As children clear saquinavir from their bodies more quickly than adults, they require a higher dose, relative to body weight. It is not a recommended therapy in the United States, as advantages to its use are few and knowledge of paediatric dosing limited. 

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.